Hpv And Other Infectious Agents In Cancer (Hb) 2010

The introduction of new HPV vaccines has garnered much research and media attention to the role of infectious agents in cancer. This current and comprehensive text provides an excellent review of the basic science and clinical implications of individual infectious agents in cancer. Covering HPV and five additional infectious agents, this text goes beyond a mere update of the literature to offer insights on the emerging possibilities for cancer prevention.

Hans Krueger, PhD, is a scientist whose firm does research, risk assessment, and consulting for anti-cancer agencies and government across Canada. He holds an appointment I the Dept. of Health Care and Epidemiology at the University of BC, Vancouver

Gavin Stuart, MD, is a Gynaecologic Oncologist and the Dean of the Faculty of Medicine at the University of British Columbia in Vancouver

Richard Gallangher is Head of the Cancer Control Research Program at the British Columbia Cancer Agency and a Clinical Professor in the School of Population and Public Health at the University of British Columbia in Vancouver

Dan Williams is a research associate with Hans Krueger and Associates in Vancouver

Jon Kerner, PhD, is Chair of the Primary Prevention Action Group for the Canadian Partnership Against Cancer in Toronto